Marshall Wace’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32.9M | Buy |
1,005,248
+11,155
| +1% | +$366K | 0.04% | 372 |
|
2025
Q1 | $32.1M | Buy |
994,093
+374,927
| +61% | +$12.1M | 0.04% | 359 |
|
2024
Q4 | $18.9M | Buy |
619,166
+167,476
| +37% | +$5.12M | 0.02% | 521 |
|
2024
Q3 | $12.7M | Buy |
451,690
+3,749
| +0.8% | +$105K | 0.02% | 614 |
|
2024
Q2 | $10.2M | Sell |
447,941
-513,418
| -53% | -$11.7M | 0.01% | 654 |
|
2024
Q1 | $29.2M | Buy |
961,359
+525,946
| +121% | +$16M | 0.04% | 337 |
|
2023
Q4 | $15.5M | Buy |
435,413
+66,752
| +18% | +$2.38M | 0.03% | 469 |
|
2023
Q3 | $16.1M | Sell |
368,661
-16,274
| -4% | -$713K | 0.03% | 456 |
|
2023
Q2 | $19M | Sell |
384,935
-166,937
| -30% | -$8.24M | 0.04% | 437 |
|
2023
Q1 | $22.9M | Buy |
+551,872
| New | +$22.9M | 0.05% | 366 |
|
2022
Q4 | – | Sell |
-14,282
| Closed | -$559K | – | 2318 |
|
2022
Q3 | $559K | Sell |
14,282
-7,262
| -34% | -$284K | ﹤0.01% | 2000 |
|
2022
Q2 | $880K | Buy |
+21,544
| New | +$880K | ﹤0.01% | 1927 |
|
2022
Q1 | – | Sell |
-723
| Closed | -$50K | – | 2606 |
|
2021
Q4 | $50K | Buy |
+723
| New | +$50K | ﹤0.01% | 2854 |
|
2021
Q1 | – | Sell |
-220,737
| Closed | -$12.3M | – | 2102 |
|
2020
Q4 | $12.3M | Buy |
+220,737
| New | +$12.3M | 0.07% | 261 |
|
2019
Q4 | – | Sell |
-57,401
| Closed | -$1.43M | – | 1631 |
|
2019
Q3 | $1.43M | Sell |
57,401
-126,840
| -69% | -$3.16M | 0.01% | 812 |
|
2019
Q2 | $5.5M | Buy |
184,241
+167,333
| +990% | +$4.99M | 0.05% | 431 |
|
2019
Q1 | $453K | Buy |
+16,908
| New | +$453K | ﹤0.01% | 1158 |
|
2016
Q2 | – | Sell |
-10,699
| Closed | -$180K | – | 970 |
|
2016
Q1 | $180K | Buy |
+10,699
| New | +$180K | ﹤0.01% | 975 |
|
2015
Q4 | – | Sell |
-43,450
| Closed | -$952K | – | 966 |
|
2015
Q3 | $952K | Buy |
+43,450
| New | +$952K | 0.01% | 627 |
|